Matthew Goodman from the Sunday Times explores the growth in electronic cigarettes
In The NewsMANCHESTER, UK, May 30, 2012 – CN Creative, Ltd. (CNC), a healthcare company providing innovative and sustainable solutions to reduce smoking and smoking-related illnesses, today reported advances in the company’s regulatory and market initiatives for its Nicadex™ electronic inhaler nicotine replacement therapy (NRT) product and Intellicig® electronic cigarettes.
Press Release4-Antibody and Evotec launch a new high-content screening platform for early antibody functionality testing
Press ReleaseJazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma
for $650 million in cash plus a potential $50 million milestone payment
CN Creative, Ltd. (CNC), a healthcare company providing innovative and sustainable solutions to reduce smoking and smoking-related illnesses, today announced that Tim Byrne has been appointed Chief Financial Officer.
Press ReleaseCellnovo today announced both the launch of the world’s only mobile-connected diabetes management system, and the start of the largest usability trial ever to investigate insulin pump technology for patients with type 1 diabetes.
Press ReleaseLinda Robson's comment as she was handed an Intellicig to try on the 'This Morning' show on ITV said it all; "Fantastic!" she exclaimed.
In The NewsAcquisition Includes a Novel Cancer Treatment in Clinical Trials for Hematologic Malignancies
Press ReleaseOral Btk inhibitor AVL-292 offers promising potential for treatment of B-cell diseases
Press Release